

| 货号 | HY564076 |
|---|---|
| 品牌 | abinScience |
| 描述 |
Anti-Human CD37 Reference Antibody (BI 836826, RUO) (HY564076) is a human monoclonal antibody detecting CD37. Expressed in Mammalian cells.
|
| 种属反应性 | Human |
| 应用 | ELISA, Bioactivity: FCM, Functional assay, Research in vivo |
| 宿主 | Human |
| 克隆类型 | Monoclonal |
| 同种型 | IgG |
| 克隆号 | BI 836826 |
| 表达系统 | Mammalian cells |
| 靶标 | CD37, Tspan-26, TSPAN26, Leukocyte antigen CD37, Tetraspanin-26 |
| 内毒素水平 | < 10 EU/mg as determined by LAL method. |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| Accession号 | P11049 |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 别名 | BI-836826, BI836826, BI836826 |
| 背景 | Leukocyte antigen CD37 (TSPAN26) is a ~31 kDa protein. Structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (TERMs), which act as platforms for receptor clustering and signaling. Participates thereby in diverse biological functions such as cell signal transduction, adhesion, migration and protein trafficking. Upon ligand binding, two signaling pathways are activated, one acting through phosphorylation by LYN leading to cell death or a survival pathway with activation of GSK3B. Plays an essential role essential for clustering of integrin ITGA4/ITGB1 and promotes its mobility in the plasma membrane of B-cells. In turn, participates in ITGA4/ITGB1 integrin-mediated antiapoptotic signaling through AKT. 1. Lapalombella, R. et al. (2012) Cancer cell 21, 694-708. PMID: 22624718 2. de Winde, CM. et al. (2016) The Journal of clinical investigation 126, 653-66. PMID: 26784544 3. Meyer-Wentrup, F. et al. (2007) Journal of immunology (Baltimore, Md. : 1950) 178, 154-62. PMID: 17182550 |
| 文献 | 1. Deborah M Stephens DO, et al. BI 836826, a Novel Fc-Engineered Antibody in Combination with Phosphoinositide-3-Kinase Inhibitor for Treatment of High Risk Chronic Lymphocytic Leukemia. Blood. Volume 124, Issue 21, 6 December 2014, Page 4681. [HY564076] |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Research Grade Anti-Human CD37/TSPAN26 (BI 836826)



24小时产品查询

扫一扫关注我们

专属渠道经理